Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis

Our findings demonstrate that GS, particularly tGS, outperforms SoC in diagnosing rare diseases, with sGS providing a more cost-effective alternative. These results suggest that GS should be considered a first-tier genetic test, offering an efficient, single-step approach to reduce the diagnostic odyssey for patients with rare diseases. The trio approach proved especially valuable for less experienced teams, as inheritance data facilitated variant interpretation and maintained high diagnostic yield, while experienced teams achieved comparable results with singleton analysis alone.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2025-09-17
DOI
https://doi.org/10.1186/s13073-025-01516-7
Citations
5
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
9.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis

Imke Poggenburg, Manuela Dittmar, Christian Schlein, Bernard Hoffmann et al.
5 citations
Genome Medicine
Genomics and Rare Diseases
9.09
article

Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis

Imke Poggenburg, Manuela Dittmar, Christian Schlein, Bernard Hoffmann, Inga Nagel, Verónica Yumiceba, Andreas Recke, Michael Salewski, Juliane Köhler, Hiltrud Muhle, Lana Harder, Saranya Balachandran, Olaf Hiort, Almuth Caliebe, Janne Wehnert, Yorck Hellenbroich, Andreas Dalski, Nadine Hornig, Janina Fuß, Varun K. A. Sreenivasan, Bianca Greiten, Alexander Maximilian Münchau, Bettina Gehring, Jelena Pozojevic, Kathryn G. Roberts, Malte Spielmann, Irina Hüning, Kristian Händler, Gloria Herrmann, Philip Rosenstiel, Sandra Wilson, Anna Möllring, Kirstin Hoff, Eva Maria Murga Penas, Jasmin Lisfeld, Rixa Woitschach, Alexander E. Volk, Sören Franzenburg, Tobias Bäumer, Britt-Sabina Löscher, Christina M. Post, Britta Hanker, Norbert Brüggemann, Nils G. Margraf, Louiza Toutouna, Theresia Herget, Dzhoy Papingi, Amelie T. van der Ven, Daniel Kaschta, Andre Franke, Inga Vater, Christine Zühlke, V. Berge, Katharina Schau-Römer, Franka Rust, Laelia Rösler, Franziska Gaass, Friederike Birgel, Anna-Sophie Liegmann, Rebecca Gembicki, Michelle Meyenborg, Monika Kautza-Lucht, Vincent Arriens, Caroline Utermann-Thüsing, Henning Nommels, Milad Al-Tawil, Kristin Grohte
article en
5 citations

Abstract

Our findings demonstrate that GS, particularly tGS, outperforms SoC in diagnosing rare diseases, with sGS providing a more cost-effective alternative. These results suggest that GS should be considered a first-tier genetic test, offering an efficient, single-step approach to reduce the diagnostic odyssey for patients with rare diseases. The trio approach proved especially valuable for less experienced teams, as inheritance data facilitated variant interpretation and maintained high diagnostic yield, while experienced teams achieved comparable results with singleton analysis alone.

Genome MedicineVol. 17(1)
Witten/Herdecke University (DE), Universität Hamburg (DE), University of Freiburg (DE), University of Zurich (CH), University Medical Center Freiburg (DE), Christian-Albrechts-Universität zu Kiel (DE), German Center for Pediatric and Adolescent Rheumatology (DE), Klinikum Itzehoe (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Klinikum Lüneburg (DE), German Centre for Cardiovascular Research (DE), University of Lübeck (DE)
Deutsches Zentrum für Herz-Kreislaufforschung, Deutsche Forschungsgemeinschaft
Openalex Percentile: Top 2%
Genomics and Rare Diseases
9.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.